Publications by authors named "S V Novosad"
During 2023, the Centers for Disease Control and Prevention (CDC) recommended the first respiratory syncytial virus (RSV) immunizations intended for widespread use in the United States to prevent severe RSV illness in infants and older adults. CDC, in collaboration with federal, public health, and academic partners, is conducting evaluations of real-world effectiveness of recommended RSV immunization products in the United States. Similar frameworks for evaluation are being applied to RSV vaccines and nirsevimab, a long-acting preventative monoclonal antibody, to estimate product effectiveness.
View Article and Find Full Text PDFInfections cause substantial morbidity and mortality among patients receiving care in outpatient hemodialysis facilities. We describe comprehensive infection prevention assessments by US public health departments using standardized interview and observation tools. Results demonstrated how facility layouts can undermine infection prevention and that clinical practices often fall short of policies.
View Article and Find Full Text PDFArticle Synopsis
- COVID-19 increases the risk of thromboembolic events like stroke and heart issues, but vaccines seem to reduce this risk.
- A study found that receiving a bivalent mRNA COVID-19 vaccine after an original monovalent one significantly decreases the likelihood of these events, showing a vaccine effectiveness of 47% for those aged 65 and older, and 51% for younger adults with severe kidney disease.
- Overall, staying updated with COVID-19 vaccinations is crucial for preventing complications related to the virus, especially thromboembolic events.
Article Synopsis
- The CDC consulted with state and local health departments from 2014 to 2022 about bronchoscope-related infections.
- Major issues identified included improper reprocessing of bronchoscopes and exposure to nonsterile water sources.
- The primary infectious pathogens were found to be water-associated bacteria linked to these gaps in practice.
Article Synopsis
- Patients undergoing maintenance dialysis are at a higher risk for SARS-CoV-2 infections and severe outcomes, including death.
- Data from the CDC between June 30, 2021, and September 27, 2022, showed an overall SARS-CoV-2 infection rate of 30.47 per 10,000 patient-weeks, with higher rates in unvaccinated individuals.
- To reduce COVID-19 risks, it's crucial for dialysis facilities to enforce infection control measures and keep both patients and staff vaccinated.